Drug Designing and Biomarkers

A biomarker is an attribute which will be studied as an indicator of pathogenic and biological operation alongside pharmacological retort to a therapeutic involvement. They indicate either normal or diseased activity within the body. Biomarkers are specific molecules, genes, gene products, hormones, cells, or enzymes.

Drug designing is an ingenious process to seek out new medication centered on the knowledge of biological target. Drug is most ordinarily a little molecule that inhibits or activates the function of a biomolecule, which successively outcomes during a therapeutic benefit to the patient. Drug design commonly but not essentially relies on computational techniques. this sort of modelling is usually mentioned to as computer-aided drug design.

 

    Related Conference of Drug Designing and Biomarkers

    April 30-30, 2021

    2nd International Conference on Nucleic Acids

    London, UK
    May 17-18, 2021

    11th World Glycobiology Congress

    Vienna, Austria
    July 26-27, 2021

    5th International Conference on Bioscience and Biotechnology

    London, Aland Islands
    March 15-16, 2021

    12th Tissue Repair and Regeneration Congress

    Dubai, UAE
    July 30-30, 2021

    Glycobiology Biochem Conference 2021

    London, UK
    August 17-18, 2021

    23rd Global Biotechnology Congress

    Rome, Italy
    September 13-14, 2021

    17th World Congress on Structural Biology

    Prague, Czech Republic
    September 27-28, 2021

    25th European Biotechnology Congress

    Dublin, Ireland
    December 01-02, 2021

    18th International Conference on Metabolomics and Proteomics

    Frankfurt, Germany
    December 03-04, 2021

    International Conference on Biotechnology

    Singapore, Singapore

    Drug Designing and Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in